Skip to main content
[Preprint]. 2023 Sep 12:2023.09.12.557258. [Version 1] doi: 10.1101/2023.09.12.557258

Figure 3. Novel ATP-competitive inhibitors of ERK1/2.

Figure 3.

(A) A panel of 17 novel ERK1/2 inhibitors surveyed in this study. Ki measurements were made using kinase assays for phosphorylation of Omnia peptide substrate (Invitrogen). (B) Variations among ERK1/2 inhibitors in their left-side, central scaffold, and a sampling of right-side substituents. (C) Contacts formed by VTX11e and GDC0994 with active site residues in 2P-ERK2, based on published X-ray structures (PDBID:6OPK, PDBID:6OPH).